Krystal Biotech, Inc. KRYS 深 沪
等待开盘 05-11 09:30:00 美东时间
305.835
+9.135
+3.08%
华盛通- 最 高306.10
- 今 开297.00
- 成交量 39.69万股
- 最 低 279.7355
- 昨 收 296.70
- 总市值 784.01万
- 52周最高 306.10
- 市盈率 静 --
- 换手率 1548.29%
- 52周最低 123.034
- 委 比 35.50%
- 总股本 2.56万
- 历史最高 306.10
- 量 比 0.98
- 振 幅 8.89%
- 历史最低 1.10
- 每 手 1
- 风险率 55.24%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For May 4, 2026
Companies Reporting Before The Bell • Pulse Biosciences (NASDAQ:PLSE) is likely...
05-04 19:11
Krystal Biotech Q1 EPS $1.83 Beats $1.39 Estimate, Sales $116.357M Beat $112.132M Estimate
Krystal Biotech (NASDAQ:KRYS) reported quarterly earnings of $1.83 per share which beat the analyst consensus estimate of $1.39 by 31.65 percent. This is a 52.5 percent increase over earnings of $1.20 per share from the
05-04 19:02
Wolfe Research Initiates Coverage On Krystal Biotech with Peer Perform Rating
Wolfe Research analyst Kalpit Patel initiates coverage on Krystal Biotech (NASDAQ:KRYS) with a Peer Perform rating.
03-27 19:55
Krystal Biotech: Q4 Earnings Insights
The earnings results for Krystal Biotech (NASDAQ:KRYS) for Q4 were made public ...
02-17 20:02
Krystal Biotech's Earnings: A Preview
Krystal Biotech (NASDAQ:KRYS) is set to give its latest quarterly earnings repo...
02-17 01:01
Earnings Scheduled For November 3, 2025
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
2025-11-03 19:11
Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference
Krystal Biotech will participate in the Goldman Sachs 46th Annual Global Healthcare Conference on June 10, 2025, in Miami. Krish S. Krishnan, the Company’s CEO, will host a fireside chat and investor meetings. A webcast of the presentation will be available starting at 2:00 pm ET on the Company’s website.
2025-06-03 12:00
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
2024-09-11 21:08
Stifel Maintains Buy on Krystal Biotech, Raises Price Target to $220
Stifel analyst Dae Gon Ha maintains Krystal Biotech (NASDAQ:KRYS) with a Buy and raises the price target from $204 to $220.
2024-09-11 19:43
Cantor Fitzgerald Reiterates Overweight on Krystal Biotech
Cantor Fitzgerald analyst Josh Schimmer reiterates Krystal Biotech (NASDAQ:KRYS) with a Overweight.
2024-08-29 23:00
